AxoGen Investor Relations Material
Latest events
Q1 2025
AxoGen
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from AxoGen Inc
Access all reports
AxoGen Inc develops and markets surgical solutions for peripheral nerve injuries. The company provides nerve grafts, connectors, and related products used by surgeons to repair damaged or severed nerves. It serves hospitals and surgical centers across the United States. The company is headquartered in Alachua, Florida, and its shares are listed on the NASDAQ.
Key slides for AxoGen Inc
Investor Day 2025
AxoGen Inc
Investor Day 2025
AxoGen Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
AXGN
Country
🇺🇸 United States